YES1 amplification as a primary driver of lung tumorigenesis and YES1/YAP1 amplifications as mediators of acquired resistance (AR) to ALK and EGFR tyrosine kinase inhibitors (TKIs) Meeting Abstract

  


Authors: Sato, H.; Kubota, D.; Paik, P. K.; Qiao, H.; Jungbluth, A. A.; Rekhtman, N.; Schoenfeld, A. J.; Yu, H. A.; Riely, G. J.; Lovly, C. M.; Ladanyi, M.; Fan, P. D.
Abstract Title: YES1 amplification as a primary driver of lung tumorigenesis and YES1/YAP1 amplifications as mediators of acquired resistance (AR) to ALK and EGFR tyrosine kinase inhibitors (TKIs)
Meeting Title: 56th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 38
Issue: 15 Suppl.
Meeting Dates: 2020 May 29-31
Meeting Location: Virtual
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2020-05-20
Language: English
ACCESSION: WOS:000560368308132
PROVIDER: wos
DOI: 10.1200/JCO.2020.38.15_suppl.e21591
Notes: Meeting Abstract: e21591 -- Source: Wos
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Natasha Rekhtman
    435 Rekhtman
  2. Helena Alexandra Yu
    291 Yu
  3. Marc Ladanyi
    1336 Ladanyi
  4. Gregory J Riely
    606 Riely
  5. Paul K Paik
    257 Paik
  6. Achim Jungbluth
    459 Jungbluth
  7. Pang-Dian Fan
    15 Fan
  8. Adam Jacob Schoenfeld
    138 Schoenfeld
  9. Daisuke Kubota
    9 Kubota
  10. Hiroki Sato
    10 Sato
Related MSK Work